UNICEL DXI ACCESS
Device
Beckman Coulter, Inc.
Total Payments
$10.8M
Transactions
170
Doctors
108
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $191,754 | 25 | 23 |
| 2023 | $1.3M | 17 | 9 |
| 2022 | $1.0M | 12 | 4 |
| 2021 | $2.5M | 38 | 31 |
| 2020 | $2.9M | 12 | 10 |
| 2019 | $2.9M | 47 | 26 |
| 2018 | $1,266 | 19 | 13 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $10.7M | 31 | 99.7% |
| Unspecified | $28,847 | 3 | 0.3% |
| Food and Beverage | $4,605 | 122 | 0.0% |
| Travel and Lodging | $2,942 | 14 | 0.0% |
Payments by Type
General
$10.7M
167 transactions
Research
$28,847
3 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| V3.0 Estriol Multiple of Medians (MOMS) Study | Beckman Coulter, Inc. | $28,847 | 0 |
Top Doctors Receiving Payments for UNICEL DXI ACCESS — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Anatomic Pathology & Clinical Pathology | Princeton, NJ | $11.64 | 1 |
| , M.D | Clinical Pathology/Laboratory Medicine | Princeton, NJ | $11.64 | 1 |
| , MD, MS | Anatomic Pathology & Clinical Pathology | Plainsboro, NJ | $11.64 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Newtown Square, PA | $11.50 | 1 |
| , MD | Cytopathology | Visalia, CA | $11.17 | 1 |
| , MD, PHD | Anatomic Pathology & Clinical Pathology | Ann Arbor, MI | $11.09 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Brick, NJ | $11.09 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Brick, NJ | $11.09 | 1 |
| , MD | Anatomic Pathology | Houston, TX | $11.08 | 1 |
Ad
Manufacturing Companies
- Beckman Coulter, Inc. $10.8M
Product Information
- Type Device
- Total Payments $10.8M
- Total Doctors 108
- Transactions 170
About UNICEL DXI ACCESS
UNICEL DXI ACCESS is a device associated with $10.8M in payments to 108 healthcare providers, recorded across 170 transactions in the CMS Open Payments database. The primary manufacturer is Beckman Coulter, Inc..
Payment data is available from 2018 to 2024. In 2024, $191,754 was paid across 25 transactions to 23 doctors.
The most common payment nature for UNICEL DXI ACCESS is "Royalty or License" ($10.7M, 99.7% of total).
UNICEL DXI ACCESS is associated with 1 research study, including "V3.0 Estriol Multiple of Medians (MOMS) Study" ($28,847).